systhiperСистемные гипертензииSystemic Hypertension2075-082X2542-2189LLC «ИнтерМедсервис»systhiper-128Research ArticleСТАТЬИARTICLESФиксированные комбинации - оптимальная стратегия лечения пациентов с артериальной гипертензией. Новая комбинация b-блокатора и диуретика - ЛодозОстроумоваО. Д.noemail@neicon.ruСредняковА. В.noemail@neicon.ruГусеваТ. Ф.noemail@neicon.ruГОУ ВПО МГМСУ Росздрава, МоскваRussian Federation20082312202252811Copyright © Остроумова О.Д., Средняков А.В., Гусева Т.Ф., 20222022Остроумова О.Д., Средняков А.В., Гусева Т.Ф.Остроумова О.Д., Средняков А.В., Гусева Т.Ф.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.syst-hypertension.ru/jour/article/view/128ReferencesИ.Е.Чазова, Л.Г.Ратова. Комбинированная терапия артериальной гипертонии. М.: Медиа Медика, 2007.И.Е.Чазова, Л.Г.Ратова. Комбинированная терапия артериальной гипертонии. М.: Медиа Медика, 2007.BENETOS A, COSOLI S, SAFAVIAN A, et al.: Efficacy, safety and effects on quality of life of Bisoprolol/Hydrochlorothiazide versus Amlodipine in elderly patients with systolic hypertension. Am Heart J 2000; 140: e14.BENETOS A, COSOLI S, SAFAVIAN A, et al.: Efficacy, safety and effects on quality of life of Bisoprolol/Hydrochlorothiazide versus Amlodipine in elderly patients with systolic hypertension. Am Heart J 2000; 140: e14.DeQUATTRO V, WEIR M. Bisoprolol fumarate/Hydrochlorothiazide 6.25 mg: A new low-dose option for first-line antihypertensive therapy. Advances in therapy 1993; 10 (5): 197-206.DeQUATTRO V, WEIR M. Bisoprolol fumarate/Hydrochlorothiazide 6.25 mg: A new low-dose option for first-line antihypertensive therapy. Advances in therapy 1993; 10 (5): 197-206.FRISHMAN WH, BRYZINSKI BS, COULSON LR, et al. A multifactorial trial design to assess combination therapy in hypertension: Treatment with Bisoprolol and Hydrochlorothiazide. Arch Intern Med. 1994; 154: 1461-1468.FRISHMAN WH, BRYZINSKI BS, COULSON LR, et al. A multifactorial trial design to assess combination therapy in hypertension: Treatment with Bisoprolol and Hydrochlorothiazide. Arch Intern Med. 1994; 154: 1461-1468.FRISHMAN WH, BURRIS JF, MROCZEK WJ, et al. First-line therapy option with low-dose Bisoprolol fumarate and low-dose Hydrochlorothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol. 1995; 35: 182-188.FRISHMAN WH, BURRIS JF, MROCZEK WJ, et al. First-line therapy option with low-dose Bisoprolol fumarate and low-dose Hydrochlorothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol. 1995; 35: 182-188.FRISHMAN WH. ZIAC National Hypertension Trial Report. March 1996.FRISHMAN WH. ZIAC National Hypertension Trial Report. March 1996.HABIB GB . Reappraisal of heart rate as a risk factor in the general population. Eur Heart J 1999; 1 (Suppl H): H2-H10.HABIB GB . Reappraisal of heart rate as a risk factor in the general population. Eur Heart J 1999; 1 (Suppl H): H2-H10.JNC VI/The Sixth Report of the Joint National Commitee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, NIH Publications 1997; No. 98-4080.JNC VI/The Sixth Report of the Joint National Commitee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, NIH Publications 1997; No. 98-4080.LEWIN AJ, LEUG MC, TARGUM S, et al. A clinical trial evaluating the 24-hour effects of Bisoprolol 5/Hydrochlorothiazide 6.25 combination in patients with mild-to-moderate hypertension. Clin Cardiol. 1993; 16: 732-736.LEWIN AJ, LEUG MC, TARGUM S, et al. A clinical trial evaluating the 24-hour effects of Bisoprolol 5/Hydrochlorothiazide 6.25 combination in patients with mild-to-moderate hypertension. Clin Cardiol. 1993; 16: 732-736.MOSER M, BLACK H. The role of combination therapy in the treatment of hypertension. Am J Hypertens 1998; 11: 73S-78S.MOSER M, BLACK H. The role of combination therapy in the treatment of hypertension. Am J Hypertens 1998; 11: 73S-78S.NEUTEL JM, ROLF CN, VALENTINE SN, et al. Low-dose combination therapy as first line treatment of mild-to-moderate hypertension: the efficacy and safety of Bisoprolol/6.25 HCTZ versus Amlodipine, Enalapril, and placebo. Cardiovasc Rev Rep. 1996; 17: 33-45.NEUTEL JM, ROLF CN, VALENTINE SN, et al. Low-dose combination therapy as first line treatment of mild-to-moderate hypertension: the efficacy and safety of Bisoprolol/6.25 HCTZ versus Amlodipine, Enalapril, and placebo. Cardiovasc Rev Rep. 1996; 17: 33-45.PAPADEMETRIOU V, NEUTEL J, NARAVAN P, et al. Comparison of Bisoprolol and low dose Hydrochlorothiazide combination with Losartan, alone or in combination with Hydrochlorothiazide, in the treatment of hypertension: a double blind, randomized, placebo controlled trial. Cardiovasc Rev Rep.; December 1998.PAPADEMETRIOU V, NEUTEL J, NARAVAN P, et al. Comparison of Bisoprolol and low dose Hydrochlorothiazide combination with Losartan, alone or in combination with Hydrochlorothiazide, in the treatment of hypertension: a double blind, randomized, placebo controlled trial. Cardiovasc Rev Rep.; December 1998.PRISANT LM, WEIR MR, PAPADEMETRIOU V, et al. Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment. Am Heart J. 1995; 130: 359-366.PRISANT LM, WEIR MR, PAPADEMETRIOU V, et al. Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment. Am Heart J. 1995; 130: 359-366.PRISANT LM, NEUTEL JM, PAPADEMETRIOU V, et al. Low-dose combination treatment for hypertension versus single-drug treatment - Bisoprolol/Hydrochlorothiazide versus Amlodipine, Enalapril, and placebo: Combined analysis of comparative studies. Am J Ther .1998; 5: 313-321.PRISANT LM, NEUTEL JM, PAPADEMETRIOU V, et al. Low-dose combination treatment for hypertension versus single-drug treatment - Bisoprolol/Hydrochlorothiazide versus Amlodipine, Enalapril, and placebo: Combined analysis of comparative studies. Am J Ther .1998; 5: 313-321.PRISANT LM, WEIR MR, FRISHMANWH, et al.: Self reported Sexual Dysfunction in Men and Woman Treated With Bisoprolol, Hydrochlorothiazide, Enalapril, Placebo, or Bisoprolol/Hydrochlorothiazide. J Clin Hypertens. 1999; 1:22-26.PRISANT LM, WEIR MR, FRISHMANWH, et al.: Self reported Sexual Dysfunction in Men and Woman Treated With Bisoprolol, Hydrochlorothiazide, Enalapril, Placebo, or Bisoprolol/Hydrochlorothiazide. J Clin Hypertens. 1999; 1:22-26.o PRISANT LM, MOSER M: Hypertension in the Elderly. Arch Intern Med. 2000; 160: 283-289.o PRISANT LM, MOSER M: Hypertension in the Elderly. Arch Intern Med. 2000; 160: 283-289.WEIR MR, PRISANT LM, PAPADEMETRIOU V et al. Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events and prior antihypertensive therapy. Am J Hypertens. 1996; 9: 854-859.WEIR MR, PRISANT LM, PAPADEMETRIOU V et al. Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events and prior antihypertensive therapy. Am J Hypertens. 1996; 9: 854-859.
The authors declare that there are no conflicts of interest present.